ArticleLeukemia & lymphoma2020

Anti-apoptotic BCL-2 family proteins confer resistance to calicheamicin-based antibody-drug conjugate therapy of acute leukemia.

Colin D Godwin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.